Ongoing research aims to better understand the mechanisms by which oncogenic viruses contribute to cancer. Scientists are investigating how viral proteins interact with host cellular machinery and identifying potential targets for therapeutic intervention. Research is also focused on developing new vaccines and antiviral therapies to prevent and treat virus-associated cancers. Advances in genomic sequencing and CRISPR-Cas9 technology are providing new insights into viral oncogenesis and opening up new avenues for personalized cancer treatment.
